{"title":"Cigarette and cannabis use and co-use among U.S. adults: An examination of prevalence and trends during 2015–2023","authors":"Joanne Constantin , Jayani Jayawardhana","doi":"10.1016/j.addbeh.2025.108521","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The shifting dynamics of cannabis legislation in the U.S. has over half the states legalizing recreational use for adults and others opting for decriminalization. As tobacco use wanes, the surge in cannabis use presents a worrisome trend among adults. This study examines cigarette and cannabis use and co-use among U.S. adults from 2015 to 2023, emphasizing key sociodemographic variations.</div></div><div><h3>Methods</h3><div>Utilizing the National Survey on Drug Use and Health, we explored the prevalence and trends of past 30-day cigarette and cannabis co-use, cannabis-only use, and cigarette-only use among adults 18 and older over three periods: 2015–2019, 2020, and 2021–2023. Analyses were conducted across various sociodemographic factors, and predictors of substance use were identified using multivariable logistic regressions.</div></div><div><h3>Results</h3><div>Cannabis-only use increased from 3.9% to 6.5% in 2015–2019, was 7.1% in 2020, and increased again from 7.9% to 10.6% in 2021–2023. Cigarette-only use decreased from 15.0% to 12.0% in 2015–2019, was 10.3% in 2020, and declined again from 10.8% to 8.8% in 2021–2023. Co-use was relatively stable across the different periods. Among socioeconomically disadvantaged adults (with lower education, income, or lacking insurance), cigarette-only use was most prevalent. In contrast, cannabis-only use predominated among more socioeconomically advantaged groups (college-educated, high-income, and privately insured).</div></div><div><h3>Conclusion</h3><div>Cannabis-only use and co-use trends pose public health risks akin to cigarettes, necessitating targeted prevention campaigns. A multi-pronged strategy of public health education, early detection, and effective treatment development is vital to prevent cannabis from becoming the next public health crisis.</div></div>","PeriodicalId":7155,"journal":{"name":"Addictive behaviors","volume":"172 ","pages":"Article 108521"},"PeriodicalIF":3.6000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive behaviors","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306460325002904","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The shifting dynamics of cannabis legislation in the U.S. has over half the states legalizing recreational use for adults and others opting for decriminalization. As tobacco use wanes, the surge in cannabis use presents a worrisome trend among adults. This study examines cigarette and cannabis use and co-use among U.S. adults from 2015 to 2023, emphasizing key sociodemographic variations.
Methods
Utilizing the National Survey on Drug Use and Health, we explored the prevalence and trends of past 30-day cigarette and cannabis co-use, cannabis-only use, and cigarette-only use among adults 18 and older over three periods: 2015–2019, 2020, and 2021–2023. Analyses were conducted across various sociodemographic factors, and predictors of substance use were identified using multivariable logistic regressions.
Results
Cannabis-only use increased from 3.9% to 6.5% in 2015–2019, was 7.1% in 2020, and increased again from 7.9% to 10.6% in 2021–2023. Cigarette-only use decreased from 15.0% to 12.0% in 2015–2019, was 10.3% in 2020, and declined again from 10.8% to 8.8% in 2021–2023. Co-use was relatively stable across the different periods. Among socioeconomically disadvantaged adults (with lower education, income, or lacking insurance), cigarette-only use was most prevalent. In contrast, cannabis-only use predominated among more socioeconomically advantaged groups (college-educated, high-income, and privately insured).
Conclusion
Cannabis-only use and co-use trends pose public health risks akin to cigarettes, necessitating targeted prevention campaigns. A multi-pronged strategy of public health education, early detection, and effective treatment development is vital to prevent cannabis from becoming the next public health crisis.
期刊介绍:
Addictive Behaviors is an international peer-reviewed journal publishing high quality human research on addictive behaviors and disorders since 1975. The journal accepts submissions of full-length papers and short communications on substance-related addictions such as the abuse of alcohol, drugs and nicotine, and behavioral addictions involving gambling and technology. We primarily publish behavioral and psychosocial research but our articles span the fields of psychology, sociology, psychiatry, epidemiology, social policy, medicine, pharmacology and neuroscience. While theoretical orientations are diverse, the emphasis of the journal is primarily empirical. That is, sound experimental design combined with valid, reliable assessment and evaluation procedures are a requisite for acceptance. However, innovative and empirically oriented case studies that might encourage new lines of inquiry are accepted as well. Studies that clearly contribute to current knowledge of etiology, prevention, social policy or treatment are given priority. Scholarly commentaries on topical issues, systematic reviews, and mini reviews are encouraged. We especially welcome multimedia papers that incorporate video or audio components to better display methodology or findings.
Studies can also be submitted to Addictive Behaviors? companion title, the open access journal Addictive Behaviors Reports, which has a particular interest in ''non-traditional'', innovative and empirically-oriented research such as negative/null data papers, replication studies, case reports on novel treatments, and cross-cultural research.